Ultrasound-guided percutaneous radiofrequency ablation combined with anti-PD-1 for the treatment of prostate cancer: an experimental study.

Compared with the other two groups, the tumor volume of mice in the radiofrequency ablation only group and the combination therapy group showed a decreasing trend in the early stage of treatment.

also in 47,180 other papers

The simple radiofrequency ablation treatment group showed a decreasing trend in tumor volume for about eight days only, followed by an increasing trend, while the combination therapy group showed a more gradual and stable change in tumor volume.

also in 63,971 other papers